section 11 - disorders of secondary hemostasis Flashcards
1
Q
two primary mechanisms of primary fibrinolysis (fibrinogenolysis)
A
- over activation of plasmin
- overwhelming of plasmin inhibitors
-> always pathological
2
Q
pathological causes of secondary fibrinolysis (fibrinolysis)
A
- ober activation of plasmin
- overwhelming of plasmin inhibitors
-> normal or pathological
3
Q
name two causes of over activation of plasmin
A
- liver disease: decrease inhibitor production (alpha 2 antiplasmin)
- exogenous activators: streptokinase, urokinase, tPA
4
Q
name the test that can monitor plasmin over activation
A
euglobulin clot lysis
- qualitative measure of endogenous fibrinolytic capability
5
Q
describe anti-thrombin deficiency
A
- thrombosis
- hereditary w/ family history
6
Q
describe activated protein C resistance (APC-R)
A
- aka factor V leiden (FVL)
- mutation of factor V gene
- FV resistant to lysis or inactivation by activated protein C (APC)
- 20% of new thrombosis cases
7
Q
what results are expected of APC-R for PT and APTT
A
- both normal
- clot can form, just can’t break down
8
Q
how is APC-R tested for
A
- APTT + FV depleted plasma + pt plasma
- one tube gets normal calcium
- one tube gets calcium and APC
- APC-R will have norma Ca response and <49 second APC response
9
Q
describe how PK and HMWK deficiencies are found
A
- typically asymptomatic
- APTT prolonged
- may see thrombosis
10
Q
describe dysfibrinogenemia
A
- mostly asymptomatic
- may restsi fibrinogenolysis or once clot is formed resists fibrinolysis
- can present as bleeding or bleeding + thrombosis
11
Q
name the two types of plasminogen deficiencies
A
- type 1: decrease in activity and antigen -> deficiency
- type 2: dysfunctional plasminogen
12
Q
describe the prothrombin mutation
A
- point mutation
- increased prothrombin levels
- thrombosis
13
Q
describe how increased homocysteine impacts coagulation
A
- defect in homocysteine = increased
- damages endothelial cells = released TF3 = coagulation